169 related articles for article (PubMed ID: 33603401)
1. IgG Fc Binding Protein (
Yuan Z; Zhao Z; Hu H; Zhu Y; Zhang W; Tang Q; Huang R; Gao F; Zou C; Wang G; Wang X
Onco Targets Ther; 2021; 14():967-977. PubMed ID: 33603401
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and immunological roles of Fc fragment of IgG binding protein in colorectal cancer.
Zhuang Q; Shen A; Liu L; Wu M; Shen Z; Liu H; Cheng Y; Lin X; Wu X; Lin W; Li J; Han Y; Chen X; Chen Q; Peng J
Oncol Lett; 2021 Jul; 22(1):526. PubMed ID: 34055091
[TBL] [Abstract][Full Text] [Related]
3.
Zhao Z; Zou S; Guan X; Wang M; Jiang Z; Liu Z; Li C; Lin H; Liu X; Yang R; Gao Y; Wang X
Front Genet; 2018; 9():650. PubMed ID: 30631342
[No Abstract] [Full Text] [Related]
4. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
Wang K; Guan C; Shang X; Ying X; Mei S; Zhu H; Xia L; Chai Z
Aging (Albany NY); 2021 Mar; 13(5):7416-7429. PubMed ID: 33686968
[TBL] [Abstract][Full Text] [Related]
5.
Jin L; Huang J; Guo L; Zhang B; Li Q; Li H; Yu M; Xie P; Yu Q; Chen Z; Liu S; Xu Y; Xiao Y; Lu M; Ye Q
J Gastrointest Oncol; 2023 Dec; 14(6):2448-2465. PubMed ID: 38196537
[TBL] [Abstract][Full Text] [Related]
6. FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma.
Yan T; Tian D; Chen J; Tan Y; Cheng Y; Ye L; Deng G; Liu B; Yuan F; Zhang S; Cai L; Chen Q
Front Oncol; 2021; 11():769033. PubMed ID: 35047393
[TBL] [Abstract][Full Text] [Related]
7. Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma.
Lin YH; Yang YF; Shiue YL
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626334
[TBL] [Abstract][Full Text] [Related]
8. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
Zhao Z; Gao Y; Guan X; Liu Z; Jiang Z; Liu X; Lin H; Yang M; Li C; Yang R; Zou S; Wang X
Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30029519
[No Abstract] [Full Text] [Related]
9. Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma.
Suo Y; Hou C; Yang G; Yuan H; Zhao L; Wang Y; Zhang N; Zhang X; Lu W
Biomol Biomed; 2023 Jul; 23(4):605-615. PubMed ID: 36803544
[TBL] [Abstract][Full Text] [Related]
10. Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer.
Kinugasa T; Akagi Y; Ochi T; Tanaka N; Kawahara A; Ishibashi Y; Gotanda Y; Yamaguchi K; Shiratuchi I; Oka Y; Kage M; Shirouzu K
Anticancer Res; 2012 Jun; 32(6):2309-14. PubMed ID: 22641667
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis.
Han SA; Chun H; Park CM; Kang SJ; Kim SH; Sohn D; Yun SH; Lee WY
Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):761-7. PubMed ID: 17168211
[TBL] [Abstract][Full Text] [Related]
12. Identification of metastasis-associated genes in colorectal cancer using metaDE and survival analysis.
Qi C; Hong L; Cheng Z; Yin Q
Oncol Lett; 2016 Jan; 11(1):568-574. PubMed ID: 26870249
[TBL] [Abstract][Full Text] [Related]
13. Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis.
Sun L; Liu X; Pan B; Hu X; Zhu Y; Su Y; Guo Z; Zhang G; Xu M; Xu X; Sun H; Wang S
J Cancer; 2020; 11(3):630-637. PubMed ID: 31942186
[No Abstract] [Full Text] [Related]
14. Prognostic Factors in Stage IV Colorectal Cancer Patients With Resection of Liver and/or Pulmonary Metastases: A Population-Based Cohort Study.
Peng P; Luan Y; Sun P; Wang L; Zeng X; Wang Y; Cai X; Ren P; Yu Y; Liu Q; Ma H; Chang H; Song B; Fan X; Chen Y
Front Oncol; 2022; 12():850937. PubMed ID: 35372009
[TBL] [Abstract][Full Text] [Related]
15. Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases.
Dong H; Tang J; Li LH; Ge J; Chen X; Ding J; Men HT; Luo WX; Du Y; Li C; Zhao F; Chen Y; Cheng K; Liu JY
Asian Pac J Cancer Prev; 2013; 14(2):909-13. PubMed ID: 23621260
[TBL] [Abstract][Full Text] [Related]
16. Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
Chen HM; Lin CC; Chen WS; Jiang JK; Yang SH; Chang SC; Ho CL; Yang CC; Huang SC; Chao Y; Liao TT; Hwang WL; Teng HW
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203267
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence.
Zou Y; Chen X; Zhang X; Shen Z; Cai J; Tan Y; Weng J; Rong Y; Lin X
Int J Hyperthermia; 2020; 37(1):944-954. PubMed ID: 32787474
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
[No Abstract] [Full Text] [Related]
19. MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.
Hunt BG; Wicker CA; Bourn JR; Lower EE; Takiar V; Waltz SE
Breast Cancer Res Treat; 2020 Jun; 181(3):529-540. PubMed ID: 32342233
[TBL] [Abstract][Full Text] [Related]
20. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
